Naslov
Challenges of in vitro drug release testing in case of advanced mucosal formulations

Autori
Jug, Mario

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
PDDS 2018 Book of Abstracts / Torchilin, Vladimir P. ; Caira, Mino R. ; Hutcheon, Gillian - Rim : Magnus Group, 2018, 52-52

Skup
2nd Global Conference on Pharmaceutics and Drug Delivery systems

Mjesto i datum
Rim, Italija, 04.06.2018. - 06.06.2018

Vrsta sudjelovanja
Radionica

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
in vitro drug releas ; mucosal delivery systems ; ocular delivery ; nasal delivery ; oromucosal delivery ; vaginal delivery ; rectal delivery

Sažetak
Mucosal route of drug delivery is recognised as suitable alternative to conventional drug administration routes (i.e. oral and parenteral), providing the possibility of more efficient local therapy with reduced systemic drug exposure as well as alternative application route for drugs that undergo extensive biotransformation in liver that leads to low and variable oral bioavailability. Nowadays, nanotechnology has been introduced to such delivery systems in order to improve their efficiency and safety. All this brings new challenges in evaluation of such formulations, prompting us to critically revise and upgrade the currently used methodology. In vitro release test is an important assay both in product development phase as well as in its quality control assurance. However, considering the diversity in formulations design, physicochemical and release characteristics of mucosal delivery systems, it is not possible to devise a single method which would be suitable for such purpose. This presentation is aimed to offer an extensive overview of currently available methodologies, both compendial and noncompendial, for in vitro drug release testing of mucosal delivery systems aimed for ocular, nasal, oromucosal, vaginal and rectal application. Critical parameters of such assays and instrumental setups will be discussed in details with a special focus on the evaluation of nanodelivery systems. In order to avoid unnecessary proliferation of equipment and method design, compendial apparatuses and methods should be used as a first approach in method development when applicable. Equipment set up, the selection of dissolution media type and volume, membrane characteristics, agitation speed, temperature, and assay analysis technique need to be carefully selected based on the properties of mucosal drug delivery system. The final goal of the method development is to obtain adequate simulation of conditions present in vivo at the application site. This would lead to development of novel biorelevant in vitro dissolution/release methods should that would enable better prediction of formulation performance in vivo and, preferably, the establishment of an in vitro/in vivo correlation.

Izvorni jezik
Engleski

Znanstvena područja
Farmacija

POVEZANOST RADA